Stocks & Investing·Aug 16, 2026

Longevity Boom Reaches America’s Pets

Pet owners are increasingly extending the longevity treatments humans pursue for themselves to their dogs, experimenting with supplements, red light therapy and drugs including rapamycin even as veterinarians urge caution about unproven treatments. Bloomberg News National Heath Care Reporter Anna Edney is on Bloomberg This Weekend and explains to hosts Joe Mathieu and Carol Massar that US pet spending is projected to reach $165 billion in 2026. (Source: Bloomberg)

Bloomberg Markets1 min readPrimary source
Longevity Boom Reaches America’s Pets
Image · Bloomberg Markets
The gist
2-point summary · 1 min

Pet owners are increasingly extending the longevity treatments humans pursue for themselves to their dogs, experimenting with supplements, red light therapy and drugs including rapamycin even as veterinarians urge caution about unproven treatments. Bloomberg News National Heath Care Reporter Anna Edney is on Bloomberg This Weekend and explains to hosts Joe Mathieu and Carol Massar that US pet spending is projected to reach $165 billion in 2026. (Source: Bloomberg)

  • Pet owners are increasingly extending the longevity treatments humans pursue for themselves to their dogs, experimenting with supplements, red light therapy and drugs including rapamycin even as veterinarians urge caution about unproven treatments.
  • Bloomberg News National Heath Care Reporter Anna Edney is on Bloomberg This Weekend and explains to hosts Joe Mathieu and Carol Massar that US pet spending is projected to reach $165 billion in 2026. (Source: Bloomberg)
$165 billion

Pet owners are increasingly extending the longevity treatments humans pursue for themselves to their dogs, experimenting with supplements, red light therapy and drugs including rapamycin even as veterinarians urge caution about unproven treatments. Bloomberg News National Heath Care Reporter Anna Edney is on Bloomberg This Weekend and explains to hosts Joe Mathieu and Carol Massar that US pet spending is projected to reach $165 billion in 2026. (Source: Bloomberg)

Integrity note  ·  The source publication didn't make the full article available — Xela wrote this version from what could be gathered (headline, public summary, and signals). Facts and attributions are preserved; for the original piece in the publisher's own words, read it at Bloomberg Markets.

What people are saying

Discussion

Hot takes

0/280

Loading takes…

Comments

Discussion · 0

Sign in to comment, like, and save articles.

Sign in

Loading comments…

Keep readingStocks & Investing desk
See all in Stocks
Newsletter

Track stocks & investing every morning.

Daily digest tuned to this beat. The 5 stories most worth your time. Unsubscribe anytime.